First in vivo gene therapy for haemophilia
A 50-year old man suffering from haemophilia A last week became the first person to receive in vivo gene therapy for his condition. The genetically inherited blood disorder affects about 1 in 10,000 men. Affected men carry a defect in the gene for the blood-clotting protein, factor VIII, which...